An interventional study of One-shot manipulation of the head of the fibula (Fibular head mobilization/manipulation) in Knee Osteoarthritis and Knee Joint Osteoarthritis, sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this pre-post randomized controlled experimental trial is to examine the effect of fibular head mobilization and manipulation on knee pain, stiffness, and range of motion (ROM) in patients with knee osteoarthritis. The study focuses on 40 participants of both genders, ranging in age from 25 to 65 years.
Main Questions
Study Design and Comparison
Researchers will compare a treatment group receiving a one-shot manipulation of the head of fibula against a comparison/control group (with study procedures also noting randomized allocation approaches).
Participant Tasks and Evaluation
Participants will:
3,295 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
This study's planned enrollment of 40 is below the median of 68 across 2,716 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →Kafrelsheikh University is the lead sponsor of 300 studies on the registry; 119 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive a one-shot manipulation of the head of the fibula
Procedure: One-shot manipulation of the head of the fibula (Fibular head mobilization/manipulation)
control group will not receive any treatment
Participants receive a single session (one-shot) of fibular head manipulation to examine its effects on knee pain, range of motion, and stiffness
Knee range of motion will be measured by electronic goniometer
Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Knee pain will be measured by numeric anlage scale
Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
Knee function will be assessed by knee joint functional index
Time frame: Pre-intervention and post-intervention (measured at baseline and immediately following the one-shot treatment session)
No study locations are listed for this record.
Plan to share: Undecided — Data will be shared upon reasonable request from the principal investigator.
Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.
Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 1 month is below that.
Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.